Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C514S340000, C514S342000, C544S331000, C544S333000, C546S270400, C546S271400
Reexamination Certificate
active
10470751
ABSTRACT:
The present invention relates to a c-Jun N-terminal kinase inhibitor containing an azole compound (I) substituted by a nitrogen-containing aromatic group having substituent(s)(except a compound represented by the formula:) or a salt thereof or a prodrug thereof.
REFERENCES:
patent: 4612321 (1986-09-01), Terao et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5792778 (1998-08-01), de Laszlo et al.
patent: 6083949 (2000-07-01), Liverton et al.
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 6962933 (2005-11-01), Ohkawa et al.
patent: 2002/0032183 (2002-03-01), LoGrasso et al.
patent: 2004/0053973 (2004-03-01), Ohkawa et al.
patent: 0 149 884 (1984-07-01), None
patent: 1070711 (2001-01-01), None
patent: 1180518 (2002-02-01), None
patent: 2000-302680 (2000-10-01), None
patent: WO 97/05877 (1997-02-01), None
patent: WO 97/35856 (1997-10-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 98/52940 (1998-11-01), None
patent: WO 98/56788 (1998-12-01), None
patent: WO 99/18942 (1999-04-01), None
patent: WO 99/21555 (1999-05-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/64418 (1999-12-01), None
patent: WO-00/26209 (2000-05-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/63204 (2000-10-01), None
patent: WO 00/64894 (2000-11-01), None
patent: WO 01/10865 (2001-02-01), None
patent: WO 01/12621 (2001-02-01), None
patent: WO 01/30778 (2001-05-01), None
patent: WO 01/57022 (2001-08-01), None
patent: WO 01/74811 (2001-10-01), None
patent: WO 02/10137 (2002-02-01), None
Lisnock et al., Biochemistry, 37, 16573-16581, 1998.
Bagowski et al., Current Biology, 11, 1176-1182, 2001.
Davis, Cell, 103, 239-252, Oct. 13, 2000.
Omura et al., J. Mol. Cell Cardiol., 31, 1269-1279, 1999.
Yue et al., Circulation Research, 82, 166-174, 1998.
Liverton, et al. “Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase” J. Med. Chem. 42:2180-2190 (1999).
Kawamoto Tomohiro
Kimura Hiroyuki
Miwatashi Seiji
Naruo Ken-ichi
Ohkawa Shigenori
Chao Mark
Powers Fiona T.
Ramesh Elaine M.
Takeda Pharmaceutical Company Limited
LandOfFree
JNK inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with JNK inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and JNK inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3741136